Advances in cellular therapy for the treatment of thyroid cancer. Jul 2010 - J Oncol; 2010:1687-8469 [PMID:20671939] [Papewalis C] [Ehlers M] [Schott M]
Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer. Jul 2008 - Clin. Cancer Res.; 14(13):1078-0432 [PMID:18594013] [Papewalis C] [Wuttke M] [Seissler J] [Meyer Y] [Kessler C] [Jacobs B] [Ullrich E] [Willenberg HS] [Schinner S] [Baehring T] [Scherbaum WA] [Schott M]
Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma. Feb 2008 - Horm. Metab. Res.; 40(2):0018-5043 [PMID:18283628] [Papewalis C] [Wuttke M] [Jacobs B] [Domberg J] [Willenberg H] [Baehring T] [Cupisti K] [Raffel A] [Chao L] [Fenk R] [Seissler J] [Scherbaum WA] [Schott M]
Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. Nov 2007 - J Transl Med; 5:1479-5876 [PMID:17894866] [Korthals M] [Safaian N] [Kronenwett R] [Maihöfer D] [Schott M] [Papewalis C] [Diaz Blanco E] [Winter M] [Czibere A] [Haas R] [Kobbe G] [Fenk R]
